| 1 |
23053629 | Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses. | 2013 Jan 1 |
1 |
| 2 |
23362894 | Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support. | 2013 Jan |
1 |
| 3 |
23994466 | Application of electrolysis for inactivation of an antiviral drug that is one of possible selection pressure to drug-resistant influenza viruses. | 2013 Dec |
1 |
| 4 |
29403810 | Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LC-MS/MS to support a bioequivalence study. | 2013 Jun |
1 |
| 5 |
20410266 | Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? | 2010 Jul |
1 |
| 6 |
20831875 | Synergistic effects in the designs of neuraminidase ligands: analysis from docking and molecular dynamics studies. | 2010 Dec 7 |
3 |
| 7 |
21351517 | [Establishment of a cell-based 2009 H1N1 influenza neuraminidase inhibitors evaluation system]. | 2010 Mar |
1 |
| 8 |
18321971 | Influenza A virus neuraminidase limits viral superinfection. | 2008 May |
1 |
| 9 |
17112602 | Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. | 2007 Mar |
1 |
| 10 |
16945126 | New low-viscosity overlay medium for viral plaque assays. | 2006 Aug 31 |
1 |
| 11 |
12857911 | Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. | 2003 Aug |
2 |
| 12 |
11270942 | Oseltamivir: a review of its use in influenza. | 2001 |
1 |
| 13 |
11825310 | Oseltamivir: a clinical and pharmacological perspective. | 2001 Oct |
2 |